If artificial tears aren't enough. The importance of inflammatory processes in dry eye disease. Practical aspects of an anti-inflammatory therapy of dry eye disease

U Pleyer, G Geerling, S Schrader, C Jacobi… - Klinische …, 2020 - europepmc.org
Dry eye disease (DED) is a heterogenous disease of the ocular surface. Multiple
pathogenetic factors are responsible for the disease process, but DED is generally linked to …

Correlation between commonly used clinical tests in the management of dry eye disease

BD Sullivan, LA Crews, EM Messmer… - … & Visual Science, 2012 - iovs.arvojournals.org
Purpose:: The purpose of this study was to evaluate the relationship between signs and
symptoms of dry eye disease in a general patient population. Methods:: In a retrospective …

[HTML][HTML] Exploring the Cutting Edge of Vision Science: New Developments in Diagnostics and Treatment of Ocular Surface in Dry Eye Disease

JM Sánchez-González, C Rocha-de-Lossada… - Life, 2023 - mdpi.com
The ocular surface refers to the outermost layer of the eye, which includes the cornea,
conjunctiva and eyelids [1]. It is a complex and delicate system that is responsible for …

[HTML][HTML] Advances in the pathophysiology, diagnosis, and treatment of dry eye disease

Y Lu, Y Wu, X Zhou, T Inomata, L Gu, X Jin… - Frontiers in …, 2022 - frontiersin.org
Dry eye disease (DED) is a multifactorial disease of the ocular surface characterized by
disruption of tear film homeostasis, causing ocular symptoms that include visual disturbance …

Integrated tear proteome and metabolome reveal panels of inflammatory-related molecules via key regulatory pathways in dry eye syndrome

X Chen, J Rao, Z Zheng, Y Yu, S Lou… - Journal of proteome …, 2019 - ACS Publications
Dry eye syndrome (DES) is a growing public health concern with a high global prevalence;
however, the fundamental processes involved in its pathogenic mechanisms remain poorly …

Emerging therapies for dry eye disease

L Mason, S Jafri, I Dortonne… - Expert opinion on …, 2021 - Taylor & Francis
ABSTRACT Introduction Dry Eye Disease (DED) is defined as a multifactorial disease of the
ocular surface characterized by a loss of homeostasis of the tear film, and a vicious cycle of …

[HTML][HTML] Proteases and their potential role as biomarkers and drug targets in dry eye disease and ocular surface dysfunction

A Ramos-Llorca, C Scarpellini… - International journal of …, 2022 - mdpi.com
Dry eye disease (DED) is a multifactorial disorder that leads to ocular discomfort, visual
disturbance, and tear film instability. DED is accompanied by an increase in tear osmolarity …

Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics

L Zhou, RW Beuerman, CM Chan… - Journal of proteome …, 2009 - ACS Publications
The proteins found in tears have an important role in the maintenance of the ocular surface
and changes in the quality and quantity of tear components reflect changes in the health of …

[HTML][HTML] Evaluation of inter-day and inter-individual variability of tear peptide/protein profiles by MALDI-TOF MS analyses

N González, I Iloro, JA Durán, F Elortza… - Molecular …, 2012 - ncbi.nlm.nih.gov
Purpose To characterize the tear film peptidome and low molecular weight protein profiles of
healthy control individuals, and to evaluate changes due to day-to-day and individual …

Tear and ocular surface disease biomarkers: A diagnostic and clinical perspective for ocular allergies and dry eye disease

T Suárez-Cortés, N Merino-Inda… - Experimental Eye …, 2022 - Elsevier
Validated biomarkers to be used as biological tools for managing ocular surface diseases
(OSDs) are still an unmet need in daily clinical practice. Many studies have contributed to …